Trial · NCT03289910
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With a Response | Up to 7 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | The Highest Grade Adverse Event Experienced | Up to 7 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Number of Participants Without Disease at Study Completion | Up to 7 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Duration of Disease-free Survival | Up to 7 months | days | MEDIAN | |
| SECONDARY | Number of Participants Still Alive at Study Completion | Up to 7 months | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Duration of Overall Survival at the Time of Study Completion | Up to 7 months | Days | MEDIAN | |
| SECONDARY | Number of Participants With Minimal Residual Disease (MRD) After Treatment | Up to 7 months | Data was not collected. | ||
| SECONDARY | Distribution of Mutations in Deoxyribonucleic Acid (DNA) Repair Defects Via Assessment in Leukemia Mutation Panel | Baseline | Data not collected. | ||
| SECONDARY | Frequency of Patients With Functional Impairment of DNA Damage Response Via Assessment With RAD51 Assay | Baseline | Data not collected. | ||
| SECONDARY | Topotecan-induced Stabilization of Topoisomerase I-DNA Covalent Complexes | Up to 7 months | Data not collected. | ||
| SECONDARY | Pharmacokinetic Sampling Studies Measured Using a Validated Liquid Chromatography/Tandem Mass Spectrometric Method in Plasma and Bone Marrow | Pre-treatment, day 1, day 8, day 14, day 15, and day 22 (approximately 24 hours post last dose) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03289910/outcomes